Literature DB >> 28658758

A Stratified Analysis of Clinical Manifestations and Different Diagnostic Methods of Neurocysticercosis-Suspected Tamilian Population Residing in and Around Puducherry.

Piriyatharisini Thamilselvan1, Krishna Raja Muthuraman2, Sheeba Arockiamary Thasan2, Gayathri Kasinathan3, Jharna Mandal4, Subhash Chandra Parija5.   

Abstract

INTRODUCTION: Human beings are accidental hosts for Cysticercus cellulosae showing varied clinical manifestations based on the site harbored by the parasitic cyst because of which disease profile remains unexplored at large. Besides this, diagnosis of the disease with a single conventional method is problematic due to lack of specificity and sensitivity. AIM: To assess the varied clinical manifestations and stratify based on imaging and serological methods for diagnosis of Neurocysticercosis (NCC) in our study population.
MATERIALS AND METHODS: A hospital-based study was carried out at Jawaharlal Institute of Post-Graduate Medical Education and Research (JIPMER), the tertiary care centre caters patients from Puducherry and surrounding regions of Tamil Nadu. This is a cross-sectional analysis of clinically and radiologically suspected cases of NCC (n=119) for a period of three years (2012 to 2015). The collection of detailed clinical history and imaging findings (MRI or CT) along with the lifestyle parameters was done after obtaining informed consent. Enzyme-Linked Immune-Electro Transfer Blot (EITB) was carried out for the samples collected from study subjects.
RESULTS: Based on dietary and environmental factors non-vegetarians, pork eaters, raw vegetable consumers and open-field defecation showed significant seropositivity. The clinical manifestations like seizures, blurring of vision and chronic headache with nausea followed by neck pain, cognitive deficits and movement disorder have higher seropositivity respectively. Generalized seizures were found to be more than focal seizures. While comparing the imaging and serological tests for NCC diagnosis, the positivity rate was 46.2% considering positive by both methods; but 18.5% of sero-positive cases were imaging negative, and 16% of the sero-negative cases were imaging positive. The study showed a predominance of multiple cysts (62%) in cases with cystic lesions.
CONCLUSION: This study is first of its kind in associating varied and less commonly explored clinical manifestations with two different diagnostic measures in practice and its importance among our study settings. These manifestations must be considered as strong disease entities of NCC, which has to be suggested for differential diagnosis, and cannot be left ignored. Combinatorial diagnostic methods like serology and imaging techniques should be followed in diagnosis and assessing the disease burden.

Entities:  

Keywords:  Active and inactive epilepsy; Cystic lesions; Definitive neurocysticercosis; Probable neurocysticercosis

Year:  2017        PMID: 28658758      PMCID: PMC5483660          DOI: 10.7860/JCDR/2017/23711.9844

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  32 in total

Review 1.  Neurocysticercosis: a review of current status and management.

Authors:  Sumit Sinha; B S Sharma
Journal:  J Clin Neurosci       Date:  2009-04-25       Impact factor: 1.961

2.  Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India.

Authors:  V Rajshekhar; M Venkat Raghava; V Prabhakaran; A Oommen; J Muliyil
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

Review 3.  Proposed diagnostic criteria for neurocysticercosis.

Authors:  O H Del Brutto; V Rajshekhar; A C White; V C Tsang; T E Nash; O M Takayanagui; P M Schantz; C A Evans; A Flisser; D Correa; D Botero; J C Allan; E Sarti; A E Gonzalez; R H Gilman; H H García
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

4.  Detecting spatial clusters of Taenia solium infections in a rural block in South India.

Authors:  M Venkata Raghava; V Prabhakaran; T Jayaraman; J Muliyil; A Oommen; P Dorny; J Vercruysse; V Rajshekhar
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-07-17       Impact factor: 2.184

5.  A serological study of cysticercosis in patients with HIV.

Authors:  Subhash Chandra Parija; A R Gireesh
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2009 Jul-Aug       Impact factor: 1.846

6.  Estimation of the health and economic burden of neurocysticercosis in India.

Authors:  B B Singh; M S Khatkar; J P S Gill; N K Dhand
Journal:  Acta Trop       Date:  2016-01-21       Impact factor: 3.112

Review 7.  Clinical manifestations associated with neurocysticercosis: a systematic review.

Authors:  Hélène Carabin; Patrick Cyaga Ndimubanzi; Christine M Budke; Hai Nguyen; Yingjun Qian; Linda Demetry Cowan; Julie Ann Stoner; Elizabeth Rainwater; Mary Dickey
Journal:  PLoS Negl Trop Dis       Date:  2011-05-24

Review 8.  Neurocysticercosis: neglected but not forgotten.

Authors:  Christina M Coyle; Siddhartha Mahanty; Joseph R Zunt; Mitchell T Wallin; Paul T Cantey; A Clinton White; Seth E O'Neal; Jose A Serpa; Paul M Southern; Patricia Wilkins; Anne E McCarthy; Elizabeth S Higgs; Theodore E Nash
Journal:  PLoS Negl Trop Dis       Date:  2012-05-29

9.  Prevalence of Neurocysticercosis in People with Epilepsy in the Eastern Province of Zambia.

Authors:  Kabemba E Mwape; Joachim Blocher; Jasmin Wiefek; Kathie Schmidt; Pierre Dorny; Nicolas Praet; Clarance Chiluba; Holger Schmidt; Isaac K Phiri; Andrea S Winkler; Sarah Gabriël
Journal:  PLoS Negl Trop Dis       Date:  2015-08-18

10.  High prevalence of cysticercosis in people with epilepsy in southern Rwanda.

Authors:  Ruth Rottbeck; Jules Fidèle Nshimiyimana; Pierrot Tugirimana; Uta E Düll; Janko Sattler; Jean-Claudien Hategekimana; Janvier Hitayezu; Irmengard Bruckmaier; Matthias Borchert; Jean Bosco Gahutu; Sebastian Dieckmann; Gundel Harms; Frank P Mockenhaupt; Ralf Ignatius
Journal:  PLoS Negl Trop Dis       Date:  2013-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.